LOW GRADE OVARIAN SEROUS ADENOCARCINOMA
Clinical trials for LOW GRADE OVARIAN SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE OVARIAN SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOW GRADE OVARIAN SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested to control recurrent ovarian cancer
Disease control Recruiting nowThis study is testing whether a combination of two drugs—nab-sirolimus and the hormone therapy fulvestrant—can help control recurrent low-grade ovarian cancer. It will enroll 37 patients who have seen their cancer return after prior treatment. Researchers will measure how well th…
Matched conditions: LOW GRADE OVARIAN SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Massive cancer database aims to unlock secrets of rare tumors
Knowledge-focused Recruiting nowThis study is collecting medical information from 2000 patients with low-grade ovarian or peritoneal cancers to build a comprehensive database. Researchers will review medical records and store tissue samples to better understand these specific tumor types. The goal is to analyze…
Matched conditions: LOW GRADE OVARIAN SEROUS ADENOCARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:56 UTC